Brands, Medical Use, Clinical Data
Drug Category
Dosage Forms
Brands / Synonyms
Anti HER2; Herceptin; Herceptin (Genentech)
; Ig gamma-1 chain C region
Description
A recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein. Produced in CHO cell culture.
Indications
For treatment of HER2-positive metatsatic breast cancer
Pharmacology
Used in the treatment of HER2-positive breast cancer. HER2 protein overexpression is observed in 25%-30% of primary breast cancers.Trastuzumab has been shown, in both in vitro assays and in animals, to inhibit the proliferation of human tumorcells that overexpress HER2. It is a mediator of antibody dependent cellular cytotoxicity, in that the binding of the antibody to HER2 overexpressing cells leads to preferential cell death.
Mechanism of Action
Trastuzumab binds to the HER2 (or c-erbB2) proto-oncogene, an EGF receptor-like protein found on 20-30% of breast cancer cells. The binding leads to antibody mediated (complement mediated) killing of the HER2 positive cells.
Absorption
Not Available
Toxicity
Not Available
Biotrnasformation / Drug Metabolism
Most likely removed by opsonization via the reticuloendothelial system.
Contraindications
Not Available
Drug Interactions
Not Available
|